Substance / Medication

Salicylic acid

Overview

Active Ingredient
salicylic acid
RxNorm CUI
9525

Indications

For Dermatologic Use: Salicylic Acid 6% Gel is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders including verrucae, and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris keratosis pilaris, pityriasis rubra pilaris, and psoriasis (including body, scalp, palms and soles). For Podiatric Use: Salicylic Acid 6% Gel is a topical aid in the removal of excessive keratin on dorsal and plantar hyperkeratotic lesions.

Labeler: PureTek CorporationUpdated: 2026-02-06T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Salicylic Acid 6% Gel Salicylic Acid 6% Gel should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients.should not be used in children under 2 years of age.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

240 trials linked to this intervention

240
Total Trials
29
Recruiting
125
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Acetylsalicylic acid dosed at bedtime vs. dosed in the morning for circadian rhythm of blood pressure- a systematic review and meta-analysis.
Nadeem Abdullah, Rais Taruba, Aamir Minahil et al. · Front Cardiovasc Med · 2024
PMID: 39502192Meta-AnalysisFull text (PMC)
Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case-control and cohort studies.
Longo Salvatore, Altobelli Emma, Castellini Chiara et al. · Int J Colorectal Dis · 2022
PMID: 35094111Meta-Analysis
The influence of acetylsalicylic acid on bone regeneration: systematic review and meta-analysis.
de Souza Rendohl E, Miziara L N B, Pimentel A C et al. · Br J Oral Maxillofac Surg · 2021
PMID: 34736809Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Salicylic acid (substance)
SNOMED CT
387253001
UMLS CUI
C0036079
RxNorm CUI
9525
Labeler
PureTek Corporation

Clinical Data

This intervention maps to 6 entities in the Healos knowledge graph.

6
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
240
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.